Search

Displaying all 3 results
DrugBest match

Fostamatinib

go.drugbank.com/drugs/DB12010
ApprovedInvestigational

Fostamatinib has been investigated for the treatment and basic science of Rheumatoid Arthritis and Immune Thrombocytopenic Purpura (ITP). It was approved on April 17, 2018, under the trade name Tavalisse for use in ITP . Fostamatinib has also been granted orphan drug status by the FDA . Recently, fostamatinib has be...

  1. Pathway

    Fostamatinib Predicted Metabolism Pathway

    smpdb.ca/view/SMP0174744
    Metabolic

    Metabolites of Fostamatinib are predicted with biotransformer.

    Drugs: Mesoheme · Fostamatinib
  2. Indication

    Chronic immune thrombocytopenia

    go.drugbank.com/conditions/DBCOND0023252
    Drugs: Eltrombopag · Fostamatinib · Lusutrombopag · Rilzabrutinib · Romiplostim